STOCK TITAN

Viatris 2023 Sustainability Report: Advocating for Patients

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Viatris' 2023 Sustainability Report highlights the company's commitment to patient advocacy and empowerment. The report outlines various collaborations and initiatives undertaken in 2023, including:

  • Partnering with Allergy & Anaphylaxis Australia for awareness campaigns and patient education
  • Sponsoring the COPD Foundation's Lace up for Lungs campaign in the U.S.
  • Supporting the Cystic Fibrosis Foundation and Boomer Esiason Foundation
  • Collaborating with multiple sclerosis advocacy associations
  • Creating the MyHealthMyLife website for disease awareness
  • Partnering with the Active Citizen Network to strengthen patients' voices in health policies

These efforts aim to provide patients and caregivers with access to information, raise awareness, and empower them to actively participate in their healthcare journey.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+3.62% News Effect

On the day this news was published, VTRS gained 3.62%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NORTHAMPTON, MA / ACCESSWIRE / September 12, 2024 / With people at the heart of our mission, Viatris is committed to representing and capturing the diverse voices of patients and caregivers and joining together for advocacy. As both a caretaker and a caregiver, people often experience a lack of power and limited access to information at a time when they may be at their most vulnerable. We work with many patient advocacy organizations to help provide patients and caregivers with access to information, grow their knowledge and leverage the power of their collective voice to raise awareness. Together with patient organizations and academia, we engage in education, research, sponsorships, awareness events and policy efforts with the goal to empower patients.

In 2023, this included:

  • Collaborated with Allergy & Anaphylaxis Australia on awareness campaigns, patient education and resources to help ensure familiarity with how and when to use epinephrine auto-injectors. We also collaborate with the Australian Society of Clinical Immunology (ASCIA) to promote, evaluate, and update ASCIA allergy and anaphylaxis e-training courses and online resources.

  • Sponsored the COPD Foundation's Lace up for Lungs campaign in the U.S., which is instrumental in advancing the organization's mission to help millions of people live longer and healthier lives by advancing research, advocacy and awareness to stop COPD and related lung diseases

  • Participated in and sponsoring the Cystic Fibrosis Foundation's annual Corporate Cup. More than a dozen colleagues took part in recreation and sporting events between area companies, while raising awareness and money to support the foundation.

  • Supported our longtime U.S.-based partner the Boomer Esiason Foundation to provide education and resources to families affected by cystic fibrosis and the organization's BEF Financial Hardship Fund, which provides a temporary source of funding for families during a time of unexpected adversity or emergency

  • Partnered with several multiple sclerosis (MS) advocacy associations, including the Multiple Sclerosis Association of America, the National MS Society and others to provide educational resources and support for people living with this autoimmune disease

  • Collaborated with patients' organizations and medical societies to create the MyHealthMyLife website to support patients group to provide additional resources on diseases awareness

  • Supported long-term partner Brazilian Association of Family, Friends and People with Affective Disorders (ABRATA) on several initiatives including disease awareness and advocacy

  • Partnered with the Active Citizen Network (ACN), which supports several regional and local activities on European Patients' Rights Day to strengthen patients' voice in shaping and influencing health policies focusing on the healthcare workforce crisis

  • Participated in the working group of Gravitate Health, a publicprivate partnership with 40 members from Europe and the U.S., which works to equip and empower people with digital information tools that make them confident, active and responsive in their patient journey

View the full 2023 Sustainability Report.



View additional multimedia and more ESG storytelling from Viatris on 3blmedia.com.

Contact Info:
Spokesperson: Viatris
Website: https://www.3blmedia.com/profiles/viatris
Email: info@3blmedia.com

SOURCE: Viatris



View the original press release on accesswire.com

FAQ

What patient advocacy initiatives did Viatris (VTRS) undertake in 2023?

In 2023, Viatris (VTRS) collaborated with various organizations, including Allergy & Anaphylaxis Australia, COPD Foundation, Cystic Fibrosis Foundation, and multiple sclerosis advocacy associations. They also created the MyHealthMyLife website and partnered with the Active Citizen Network to support patient advocacy and empowerment.

How did Viatris (VTRS) support COPD awareness in 2023?

Viatris (VTRS) sponsored the COPD Foundation's Lace up for Lungs campaign in the U.S. in 2023. This campaign aims to advance research, advocacy, and awareness to stop COPD and related lung diseases, helping millions of people live longer and healthier lives.

What initiatives did Viatris (VTRS) support for cystic fibrosis in 2023?

In 2023, Viatris (VTRS) participated in and sponsored the Cystic Fibrosis Foundation's annual Corporate Cup. They also supported the Boomer Esiason Foundation, providing education and resources to families affected by cystic fibrosis and contributing to the BEF Financial Hardship Fund.

How is Viatris (VTRS) supporting multiple sclerosis patients?

Viatris (VTRS) partnered with several multiple sclerosis (MS) advocacy associations in 2023, including the Multiple Sclerosis Association of America and the National MS Society. These partnerships aim to provide educational resources and support for people living with this autoimmune disease.

What digital health initiative did Viatris (VTRS) participate in during 2023?

In 2023, Viatris (VTRS) participated in the working group of Gravitate Health, a public-private partnership with 40 members from Europe and the U.S. This initiative works to equip and empower people with digital information tools to make them confident, active, and responsive in their patient journey.
Viatris Inc Ord Shs

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

14.35B
1.15B
0.28%
85.61%
3.48%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG